Scott Sarazen

Ernst & Young

As the Biotechnology Markets Leader, Scott is responsible for all aspects of Ernst & Young's global marketing, communication and go-to-market strategies for the biotechnology industry. In this role, Mr. Sarazen and his team serve as the primary conduit between the firm and the biotechnology and medical device industries for the purposes of identifying and tracking the changing landscape of these dynamic sectors. The Markets Leader also oversees thought leadership, including the production of Beyond Borders, Ernst & Young's annual report on the biotechnology industry. Scott is resident at Ernst & Young's Global Biotechnology Center based in Boston. Prior to joining Ernst & Young, Mr. Sarazen has enjoyed over 18 years of experience supporting strategic operations and business development in the biotechnology and biomedical industries in roles including: Senior Vice President of Corporate Development at Straumann, North America and Director of Global Planning and Development at Genzyme Corporation. Scott has also served in public roles as both the Senior Vice President for Life Sciences with MassDevelopment and as a special consultant to the Chief Economic Development Officer of the City of Boston for the purposes of advocating the expansion of the biomedical economies in Massachusetts. Mr. Sarazen has a BS in Engineering from Worcester Polytechnic Institute and a MS in Management from Lesley University.